Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
First Investment: 2022
The effort required to build a traditional pharmaceutical or biotech company is part of what makes drug development so slow and expensive. The DVLP Medicines platform digitizes and streamlines the process, supporting project-focused work around individual molecules. On the platform, project leaders can recruit investors, connect with vendors, and meet regulatory requirements, while smart contracts provide an immutable record at every turn. DVLP will use the platform to rescue desperately needed but stranded medicines from broken therapeutic markets, such as new antibiotics to combat antimicrobial resistance and therapeutics that treat rare diseases.
